Coronavirus information

Information on the coronavirus pandemic for our patients and visitors.

View coronavirus information

FOI 0835 2020/21 Prescribing in Ophthalmology

Freedom of Information Request: 0835 2020/21

I have a Freedom of Information request regarding Ophthalmology new patients. I would be grateful if you could answer the questions below. 

  • Within your Trust, how many patients, in the most recent 12-month period for which data are available, have received anti-VEGF treatment for the first time (i.e., excluding patients who previously had any anti-VEGF therapy)?

 

  • Of these first-time patients, please provide a breakdown by the treatments listed below:

 

Aflibercept

Brolucizumab

Dexamethasone

Ranibizumab

All other anti-VEGF treatments

  • Of these first-time patients, how many were treated for Wet Age-Related Macular Degeneration (wAMD) by each treatment?

 

Aflibercept

Brolucizumab

Dexamethasone

Ranibizumab

All Other anti-VEGF treatments

We do hold this information but not in an accessible format that allows us to easily identify patients who received anti-VEGF therapy in the last 12 months who have not previously received it.

Section 12 of the Freedom of Information (FOI) Act makes provision for public authorities to refuse requests for information where the cost of dealing with them would exceed the appropriate limit, which for local government is set at £450. This represents the estimated cost of one person spending more than 18 hours in determining whether the department holds the information, locating, retrieving and extracting the information.

The Trust does hold this information but it is not centrally recorded. To collate these figures would require a manual review of records which would take well in excess of the 18 hours allowed under the FOI Act, we are therefore exempting this information under Section 12 of the FOI Act.

 

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.